Public COA audit

Triple Agonist · Retatrutide

Audited July 28, 2026

Consistent with a legitimate COA

Document structure and test panels align with what we expect from authentic lab reports.

Legitimacy
95
Confidence
92%
Panels
5/7
Purity (printed)
99.93%

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
CR-3XAG-20-2607-PURPLE
Identity method
HPLC-RTM (chromatographic retention time comparison with reference standard)
Sample date
2026-07-06
Issue date
2026-07-21

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

5 of 7 present · 5 passed · 0 failed · 0 reported · 2 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    Confirmed (Retatrutide)

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.93%

  • Heavy metals

    Tested · passed

    Lead, arsenic, cadmium, mercury, or similar limits.

    All Not Detected (As, Cd, Pb, Hg, Cr)

  • Microbial

    Not on this COA

    Bioburden / microbial limits testing.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    0.098 EU/mL

  • Sterility

    Tested · passed

    Sterility testing where applicable.

    No Growth

  • Residual solvent / water

    Not on this COA

    Residual solvents or water content limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing

Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • Excellent purity with conformity testing

    99.93% purity confirmed across three conformity samples (mean 99.91%, std dev 0.0205%), demonstrating batch consistency. HPLC chromatogram shows clean single peak.

  • Identity confirmed by HPLC-RTM

    Retatrutide (Triple Agonist) confirmed by chromatographic retention time comparison with reference standard. Fentanyl screen negative.

  • Complete batch traceability

    Lot number CR-3XAG-20-2607-PURPLE, COA #COA-2026-AOP5MJ, Accession #ACC-2026-8209. Net peptide content 20.84 mg (labeled 20mg).

  • Dates are consistent and current

    Sample received 2026-07-06, analyzed and issued 2026-07-21. 15-day turnaround is reasonable for full panel testing.

  • ISO/IEC 17025 accredited laboratory

    ILS Laboratories, San Diego CA, claims ISO/IEC 17025 accreditation. Verification URL and QR code provided. Lab director signature present.

  • Comprehensive testing panel

    Five of seven standard panels present: identity, purity, heavy metals, endotoxin, sterility. Missing microbial (culture) and residual solvents, which is acceptable for research peptides.

  • Professional presentation

    Well-formatted two-page COA with clear tables, chromatogram, methodology notes, and conformity testing results. Consistent branding and layout.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.